ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,118.40
0.00%
Dow Jones
39,721.36
1.09%
Brent Oil
85.185
0.16%
Bitcoin
58,121.90
0.63%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
03/29/20211:23PMDow Jones NewsGlaxoSmithKline to Aide Novavax in Covid-19 Vaccine ManufactureNYSE:GSKGSK plc
03/29/202112:50PMDow Jones NewsPair of Covid-19 Drugs Performed Well in Studies, Makers SayNYSE:GSKGSK plc
03/29/20219:44AMDow Jones NewsLilly, Glaxo, Vir See Positive Study Data for Covid-19 TreatmentNYSE:GSKGSK plc
03/29/20218:30AMGlobeNewswire Inc.Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with V...NYSE:GSKGSK plc
03/29/20218:30AMPR Newswire (US)Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with V...NYSE:GSKGSK plc
03/26/20211:33PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (f-3asr)NYSE:GSKGSK plc
03/26/20219:20AMDow Jones NewsGSK, Vir Seek FDA Emergency Use Authorization for VIR-7831 in Covid-19NYSE:GSKGSK plc
03/26/20218:59AMDow Jones NewsGlaxoSmithKline, Vir Biotechnology Submit Emergency Authorization for Covid-19 Treatment to FDANYSE:GSKGSK plc
03/26/20218:30AMGlobeNewswire Inc.GSK and Vir Biotechnology Announce Submission of Emergency Use Authorization Request to FDA for VIR-7831 for the Early Treat...NYSE:GSKGSK plc
03/24/20216:57PMDow Jones NewsSlaoui Fired From Startup's Board Over Sexual-Harassment Allegations -- UpdateNYSE:GSKGSK plc
03/24/202112:23PMDow Jones NewsSlaoui Fired From Startup's Board Over Sexual Harassment AllegationsNYSE:GSKGSK plc
03/24/202110:10AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/24/202110:10AMDow Jones NewsGlaxoSmithKline Fires Moncef Slaoui Over Alleged Sexual HarassmentNYSE:GSKGSK plc
03/19/202110:49AMDow Jones NewsArtelo Biosciences Shares Rise 8% on Acceptance Into U.K Oncology ProgramNYSE:GSKGSK plc
03/18/20216:23AMDow Jones NewsGlaxoSmithKline Starts Phase 3 Severe Asthma TrialNYSE:GSKGSK plc
03/17/20212:41PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/16/20217:58AMDow Jones NewsGlaxoSmithKline, Medicago Covid-19 Vaccine Heads to Phase 3 TrialNYSE:GSKGSK plc
03/16/20217:50AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/15/20212:49PMEdgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)NYSE:GSKGSK plc
03/15/20211:50PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/15/20217:17AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/12/20213:11PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:GSKGSK plc
03/11/20219:17AMDow Jones NewsHikma, GlaxoSmithKline End Talks Over Egypt, Tunisia DealsNYSE:GSKGSK plc
03/11/20217:13AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/10/202111:04PMDow Jones NewsCovid-19 Antibody Drug Effective in Study, GlaxoSmithKline and Vir SayNYSE:GSKGSK plc
03/10/20219:18AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/03/20213:32PMDow Jones NewsVir Shares Down 29% After Update on NIH-Sponsored TrialNYSE:GSKGSK plc
03/03/202110:14AMDow Jones NewsVir, Glaxo: Data Safety Board Recommends VIR-7831 Arm of NIH Trial Be Closed to EnrollmentNYSE:GSKGSK plc
03/03/20219:00AMGlobeNewswire Inc.Vir Biotechnology and GSK Provide Update on NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVI...NYSE:GSKGSK plc
03/02/202111:26AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
NASDAQ
FCEL
FuelCell Energy
USOTC
RONN
Ronn Motor (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RXMD
Progressive Care (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
AXXA
Exxe (PK)
USOTC
VXIT
Virexit Technologies (PK)
AMEX
SPY
SPDR S&P 500
USOTC
RNVA
Rennova Health (PK)
NASDAQ
AMRN
Amarin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved